MAUDE Adverse Event Report: ETHICON INC. SURGICEL ABSORBABLE HEMOSTAT UNKNOWN; AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED

Device Problem Adverse Event Without Identified Device or Use Problem (2993)

Patient Problems Bacterial Infection (1735); Hemorrhage/Bleeding (1888); Pneumonia (2011); Pneumothorax (2012); Post Operative Wound Infection (2446)

Event Date 09/14/2023

Event Type  Injury  

Manufacturer Narrative

Product complaint # (b)(4).Component code: g07002 - device not returned this report is related to a journal article, therefore no product will be returned for analysis and the manufacturing record evaluation cannot be reviewed as the lot number has not been provided.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.1.Were the cases discussed in this article previously reported to ethicon? if yes, please provide a complaint reference number(s).2.Does the surgeon believe that ethicon products involved caused and/or contributed to the post-operative patient consequences described in the article? 3.Does the surgeon believe there was any deficiency with the ethicon products used in this procedure? 4.Was there any medical or surgical intervention performed (product removed; re-operation; re-closure; prescription steroids; antibiotics prescribed)? if so, please clarify.5.Can specific patient demographics: initials; age or date of birth; bmi; gender; patient pre-existing medical conditions (i.E.Allergies, history of reactions), all concomitant medications, past medical history, any treatment required for events, dose, frequency, and therapy dates of study drugs be provided? citation: j thorac dis 2023;15(10):5428-5441.Https://dx.Doi.Org/10.21037/jtd-23-867 this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.

Event Description

It was reported via a journal article: title: long-term clinical outcomes after initial secondary pneumothorax surgery authors: mi hyoung moon, kyung soo kim, seok whan moon citation: j thorac dis 2023;15(10):5428-5441.Https://dx.Doi.Org/10.21037/jtd-23-867 the aim of this retrospective study was to document the clinical course of secondary pneumothorax (sp) after initial surgical intervention and analyse related recurrence risk.Between janaury 1, 2001 and january 31, 2021, a total of 160 patients with secondary pneumothorax who received surgical treatments were included in the study.As surgical reinforcement, several types of fibrin glue, oxidized regenerated cellulose dressings [surgicel; ethicon (johnson & johnson), raritan, nj, usa], polyglycolic acid sheets (neoveil; gunze medical, osaka, japan), or tachosil patches (corza medical, westwood, ma, usa) were applied (alone or in combination) at surgeon¿s discretion.Reported complications include recurrence (n=?), persistent air leakage (n=?), empyema (n=?), pneumonia (n=?), and wound infection (n=?).In conclusions, in this setting, underlying lung disease of a non-copd nature is a proven risk factor for postsurgical recurrence.There is also a tendency in some patients for multiple episodes of pneumothorax within short periods of time, especially in the absence of copd.Underlying disease processes may thus merit consideration in treatment planning.

• Brand Name: SURGICEL ABSORBABLE HEMOSTAT UNKNOWN
• Type of Device: AGENT, ABSORBABLE HEMOSTATIC, NON-COLLAGEN BASED
• Manufacturer (Section D): ETHICON INC.; 1000 route 202; raritan NJ 08869
• Manufacturer (Section G): ETHICON INC.
• Manufacturer Contact: elba bello ; 1000 route 202; raritan, NJ 08869 ; 9083863534
• MDR Report Key: 19203652
• MDR Text Key: 341353842
• Report Number: 2210968-2024-04941
• Device Sequence Number: 1
• Product Code: LMG
• Combination Product (y/n): N
• Reporter Country Code: KS
• PMA/PMN Number: N12159
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Foreign,Literature,Health Professional
• Reporter Occupation: Other
• Type of Report: Initial
• Report Date: 04/29/2024

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Health Professional
• Was Device Available for Evaluation?: No
• Initial Date Manufacturer Received: 04/16/2024
• Initial Date FDA Received: 04/29/2024
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Patient Outcome(s): Required Intervention